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SUMMARY
Induction of type I interferon in response to microbial pathogens depends on a conserved cGAS-STING signaling pathway. The presence of DNA in the cytoplasm activates cGAS, while STING is activated by cyclic dinucleotides (cdNs) produced by cGAS or from bacterial origins. Here, we show that Group B Streptococcus (GBS) induces IFN-ß production almost exclusively by a cGAS-STING-dependent recognition of bacterial DNA. However, we found that GBS expressed an ectonucleotidase, CdnP, which hydrolyzes extracellular bacterial cdN. Inactivation of CdnP leads to c-di-AMP accumulation outside the bacteria and increased IFN-ß production in vitro and in vivo. Higher IFN-ß levels in vivo increased GBS killing by the host. The IFN-ß overproduction observed in the absence of CdnP is due to the cumulative effect of DNA sensing by cGAS and STING-dependent sensing of c-di-AMP. Our findings uncover the first c-di-AMP ectonucleotidase and suggest a direct bacterial mechanism dampening the activation of the cGAS-STING axis.
INTRODUCTION
Type I interferon (IFN) production is a conserved pro-inflammatory response to microbial infections (McNab et al., 2015) . However, the production of type I IFN can be beneficial or detrimental to the host in the case of bacterial infections (Monroe et al., 2010) . For instance, the type I IFN response is detrimental for the host during infections by Listeria monocytogenes, Mycobacterium tuberculosis and Neisseria gonorrhoeae (Archer et al., 2014; Manzanillo et al., 2012) . In contrast, type I IFN is critical for host defenses against certain extracellular pathogens such as Streptococcus species (e.g., S. pneumoniae, S. pyogenes, S. agalactiae) and
Staphylococcus aureus (Gratz et al., 2011; Mancuso et al., 2007; Parker et al., 2014) . Induction of type I IFN in response to bacteria is dependent on two main pathways (Monroe et al., 2010) . The first pathway is a Toll-like receptor 4 (TLR4)-dependent sensing of LPS molecules present on the surface of gram-negative bacteria. The second pathway is a cytosolic sensing of bacterial nucleic acids, mainly double-stranded DNA, present in the host cytoplasm.
Several cytoplasmic DNA receptors have been identified, among which the recently described cyclic GMP-AMP synthase (cGAS) has a critical role (Barber, 2014; Cai et al., 2014; Paludan, 2015) . The cGAS enzyme is activated by DNA binding and produces a specific eukaryotic cyclic dinucleotide (cdN), abbreviated hereafter as 2'3' cGAMP (Ablasser et al., 2013; Gao et al., 2013a) which acts as a second messenger to activate the endoplasmic reticulum (ER)localized protein stimulator of IFN genes (STING). Once activated, STING recruits TANK-Binding Kinase 1 (TBK1) to phosphorylate interferon regulatory factor 3 (IRF3), ultimately leading to type I IFN production.
Prior to the discovery of 2'3' cGAMP, only bacteria were known to synthesize cdNs. All bacteria synthesize at least one cdN, either c-di-AMP, c-di-GMP, and/or cGAMP, which acts as a secondary messenger in several processes such as biofilm formation, cell wall homeostasis, independent pathway in murine macrophages in response to live bacteria (Charrel-Dennis et al., 2008) . Here we report that GBS induces type I IFN by a cGAS-and STING-dependent pathway, primarily upon recognition of bacterial DNA, in murine macrophages and human monocytes.
However, we observed that GBS degrades c-di-AMP present outside the bacteria. We showed that c-di-AMP is produced by GBS, but the amount of extracellular c-di-AMP is kept low by the activity of the cell wall-anchored ectonucleotidase CdnP. The CdnP enzyme is unrelated to the currently known bacterial cdN phosphodiesterases and acts sequentially with a second ectonucleotidase, NudP (Firon et al., 2014) , to degrade extracellular c-di-AMP into adenosine.
We show that inactivation of CdnP leads to c-di-AMP accumulation outside the bacteria and an overproduction of IFN-ß due to a STING-dependent, cGAS-independent, recognition of c-di-AMP. We thus report a novel and direct mechanism used by a bacteria to dampen IFN-ß production by degrading c-di-AMP to prevent STING overactivation.
RESULTS

cGAS is the main sensor for IFN induction in response to WT GBS.
We previously demonstrated that type I IFN production in response to GBS relies on GBS phagocytosis, alteration of the phagolysosomal membrane by the bacterial pore-forming toxin ßhemolysin/cytolysin, and the release of bacterial DNA into the cytosol (Charrel-Dennis et al., 2008) . To clarify the role of the DNA sensors cGAS and the DNA-binding PYHIN family member, IFI16, in GBS infection, human THP-1 cells were infected with GBS bacteria. We observed robust IFN-ß induction by WT GBS infection in THP-1 cells ( Figure 1A ) consistent with our previous results in murine bone marrow-derived macrophages (BMDMs) (Charrel-Dennis et al., 2008) . Using cGAS -/or IFI16 -/-THP-1 cell lines, we demonstrate that IFN-ß induction by WT GBS depends mostly, but not exclusively, on cGAS ( Figure 1A) , and is independent of IFI16 ( Figure 1B ). In agreement with cGAS acting upstream of the adapter STING, we observed a similar drop in IFN-ß induction by WT GBS in STING -/-THP-1 cells ( Figure 1C ). The level of IFN-ß induction observed at the mRNA level was confirmed by the quantification of IP-10, a surrogate cytokine for type I IFN expression, in WT, cGAS -/-, and STING -/-THP-1 cells ( Figures 1D and 1E ). Transfection of purified GBS DNA confirmed the critical function of the cGAS-STING axis for IFN-ß production in response to cytoplasmic DNA Similar results were obtained with murine BMDMs. Induction of IFN-ß in BMDMs infected with GBS is strongly and similarly decrease in cGAS -/and STING -/cells (Figures 1F and 1G) . The cGAS-STING axis has only a slight effect on TNF- expression ( Figures 1F and   1G ) demonstrating the conserved and specific role of the cGAS-STING axis in response to GBS infection. Overall, we confirmed our previous study describing that WT GBS induces type I IFN by a DNA-dependent sensing pathway, and identified cGAS as the main upstream component mediating this response. In addition, the similar response observed in cGAS -/and STING -/cells was consistent with cGAS relaying the information to STING through the synthesis of 2'3' cGAMP and suggests that activation of STING directly by GBS cdN, independently of cGAS, plays a minor role.
GBS hydrolyzes extracellular c-di-AMP
To understand the putative role of bacterial cdN in IFN-ß induction by WT GBS, we looked for genes involved in cdN synthesis in the GBS genome. Homologues of the DacA di-adenylate cyclase (Gbs0902) and of the GdpP intracellular c-di-AMP phosphodiesterase (Gbs2100), the two conserved enzymes involved in c-di-AMP synthesis and intracellular degradation (Corrigan and Grundling, 2013) were identified, in contrast to genes encoding enzymes involved in c-di-GMP and cGAMP metabolism (Davies et al., 2012; Romling et al., 2013) . Consistently, c-di-AMP, but not c-di-GMP or cGAMP, was detected in GBS extracts (Figure 2A ).
Cyclic-di-AMP is released outside bacteria by a mechanism involving non-specific transporters (Kaplan Zeevi et al., 2013; Woodward et al., 2010; Yamamoto et al., 2012) , and could also occur through spontaneous lysis (Oliveira et al., 2012) . However, the absence of STING activation independent of cGAS suggests a low level of c-di-AMP outside GBS. We therefore hypothesized that GBS may degrade extracellular c-di-AMP. To test this hypothesis, intact WT GBS cells were incubated with exogenously added c-di-AMP. In this condition, the concentration of extracellular c-di-AMP decreases linearly ( Figure 2B ) coinciding with an accumulation of extracellular adenosine ( Figure 2C ).
The formation of adenosine suggests the involvement of the NudP ectonucleotidase that degrades extracellular ADP and AMP into adenosine (Firon et al., 2014) . Interestingly, the rate of c-di-AMP hydrolysis is slower with ∆nudP mutant cells compared to WT bacteria ( Figure 2B) and AMP production is observed instead of adenosine formation ( Figure 2C ). Overall, these results demonstrate that GBS hydrolyzes extracellular c-di-AMP and suggest that an enzyme present at the bacterial surface hydrolyzes extracellular c-di-AMP into AMP, which is further processed into adenosine by NudP.
The ectonucleotidase CdnP degrades extracellular c-di-AMP
Among the approximately 30 GBS proteins with a cell wall anchoring motif (Glaser et al., 2002) , we identified a second ectonucleotidase Gbs1929 (NCBI WP_000033934.1), hereafter named CdnP for cyclic dinucleotide phosphodiesterase. CdnP is an 800-aa protein containing a signal peptide, a canonical LPxTG cell surface localization motif, a 5'-nucleotidase domain, and a metallophosphoesterase domain ( Figure 2D ). CdnP has a conserved NHE motif (residues 198-200) in which the histidyl residue is essential for metallophosphodiesterase activity (Matange et al., 2015; Zimmermann et al., 2012) . Therefore, we engineered the GBS chromosome to replace the His199 residue with an alanine ( Figure 2D ). The resulting inactivated CdnP mutant (∆cdnp*) is unable to hydrolyze exogenously added c-di-AMP ( Figures 2B and 2C ). This result indicates that CdnP is indeed the enzyme responsible for c-di-AMP extracellular degradation by GBS.
To further demonstrate that c-di-AMP is released extracellularly by GBS, we analyzed WT and ∆cdnp* supernatants by HPLC. Almost no c-di-AMP was detected in the WT GBS supernatant, in contrast to the ∆cdnp* supernatant ( Figure S2A ). To compare the amount of extracellular c-di-AMP, we adapted a c-di-AMP quantification assay based on the S. pneumoniae c-di-AMP binding protein CabP . Resin-bound CabP was used to bind c-di-AMP present in GBS supernatants and bound nucleotides were quantitated by HPLC after elution ( Figure S2B ). Supernatants of WT and WTbk control (the WT CdnP strain isogenic to ∆cdnP*) contain a similar low amount of extracellular c-di-AMP. In contrast, the ∆cdnP* supernatant contains 5-to 7-fold more extracellular c-di-AMP ( Figure 2E ). These results strongly suggest that the low level of extracellular c-di-AMP observed in WT supernatants is due to the CdnP activity.
CdnP has 2',3' cNMP activity
CdnP is annotated as a putative bifunctional 2',3'-cyclic-nucleotide 2'-phosphodiesterase and 3'-nucleotidase (EC 3.1.4.16) based on homology with CpdB from Escherichia coli. CpdBrelated proteins are predicted to hydrolyze the cyclic phosphoester linkage of 2',3' cyclic nucleotides (2',3' cNMP) to give 2' or 3' monophosphate nucleotides (2' NMP or 3' NMP), among which the 3' NMP can be further hydrolyzed by the same enzyme to give the corresponding nucleoside and inorganic phosphate (Anraku, 1964) .
To characterize the enzymatic activity, we purified the recombinant rCdnP ( Figure 2D : residues 28-798). The rCdnP protein is soluble and has an apparent molecular mass of about 80 kDa, in agreement with its theoretical 82 kDa mass. Sedimentation velocity experiments revealed an s20,w of 4.2 S and a frictional ratio of 1.6, giving a calculated mass of 80 kDa, corresponding to a monomeric protein displaying an elongated shape ( Figure 3A ). Purified rCdnP converts the predicted substrate 2',3' cNMP to nucleoside and phosphate ( Figure S3A ). The optimal enzymatic activity is at pH 7.5 ( Figure 3B ) and is dependent on manganese with an optimum near 0.5 mM ( Figure 3C ). There is a stringent Mn 2+ requirement since only low activity was observed with Ca 2+ and no activity was detected with other divalent ions such as Mg 2+ , Co 2+ , or Zn 2+ ( Figure   3C ). The substrate specificity and kinetic parameters of rCdnP were determined in the presence of 2 mM Mn 2+ at pH 7.5. The Michaelis constants of rCdnP are shown in Table 1 and the highest specific activity was obtained with 2',3' cUMP ( Figure S3A ). In contrast, CdnP has no activity on 3',5' cNMP, including the universal second messenger cAMP (Table 1 and Figure S3A ). Since 2',3' cNMPs are instable in vivo (Rao et al., 2010) , we hypothesized that they are not the CdnP physiological substrates.
CdnP is a 3'5' cyclic dinucleotide 3' phosphodiesterase
Based on our observation with intact GBS cells, we further characterized the substrate specificity of CdnP. Remarkably, bacterial cdNs were hydrolyzed by rCdnP to give the corresponding 5' NMP nucleotides (Figures 3D and 3E) . We determined the Michaelis constants for c-di-AMP, c-di-GMP, and cGAMP (Table 1) and observed the highest specific activity (7 µmol Pi/ min/ mg prot) with c-di-AMP ( Figure S3B ). In agreement with the data obtained with GBS cells, we observed that CdnP and NudP cooperate to cleave c-di-AMP into adenosine. CdnP cleaves the two 3' phosphodiester bonds of c-di-AMP to give two 5' AMP molecules, which are further cleaved by NudP to give two adenosine and two inorganic phosphates ( Figure S3B ).
Bacterial cdNs are made of two 3',5' phosphodiester linkages connecting the base units. In contrast, the metazoan 2'3' cGAMP (>G(2',5')pA(3',5')p>) contains one 2',5' and one 3',5' phosphodiester linkage (Ablasser et al., 2013; Gao et al., 2013a) . While CdnP hydrolyzes the bacterial cGAMP containing two 3',5' linkages, no activity was detected on the metazoan 2'3' cGAMP (Table 1 and Figure S3B ). Interestingly, addition of 2'3' cGAMP does not inhibit the activity of rCdnP on the other substrates (data not shown). On the other hand, non-hydrolysable c-di-NMP analogs, such as cyclic diadenosine monophosphorodithioate, Rp-isomers (Rp, Rp-c-diAMPSS), a di-thiophosphate analogue of c-di-AMP, inhibit rCdnP activity ( Figure S3C ). In addition, modifications of the 2', 2" positions of the ribose, by adding fluor or O-methyl-ribose, influence the catalytic efficiency of rCdnP (data not shown). It is thus likely that the metazoan 2'3' cGAMP is not a substrate for rCdnP because the specific conformation imposed by the 2',5' linkage may hinder the substrate-enzyme interaction (Collins et al., 2015) .
To confirm the enzymatic activity, we purified the recombinant rCdnP* where the CdnP critical His199 residue was mutated to Ala. In similar conditions, rCdnP* was totally inactive whatever the substrate used ( Figure 3E and data not shown). These results demonstrate that CdnP is a 3',5' cyclic dinucleotide 3' phosphodiesterase.
Degradation of c-di-AMP by CdnP limits STING activation
IFN-ß induction in response to GBS appears mainly dependent on DNA recognition by cGAS while the direct activation of STING by c-di-AMP has at best a minor role when using WT bacteria ( Figure 1 ). However, WT GBS degrades c-di-AMP present outside the bacteria due to the CdnP ectonucleotidase (Figures 2 and 3) . To uncover the effect of CdnP, we compared IFN-ß induction in THP-1 cells infected with WT GBS, ∆cdnP* mutant, or the isogenic WTbk control.
At all MOIs tested, transcription of IFN-ß is higher in THP-1 cells infected with the ∆cdnP* mutant as compared to those infected with the WT and WTbk controls ( Figure 4A ). This increase in IFN-ß induction is not due to difference in bacterial growth rate, phagocytosis or intracellular killing, and is specific since TNF- induction is similar between ∆cdnP* and WT bacteria
To characterize the respective role of GBS DNA and c-di-AMP on type I IFN induction, cGAS -/and STING -/-THP-1 cells were infected with the same strains. As observed previously ( Figure 1 ), IFN-ß induction and IP-10 production by the GBS WT and WTbk controls is similarly decreased in both cGAS -/and STING -/cell lines, with a 64-70% and 70-75% decrease respectively ( Figure 4B -E), confirming that cGAS is the main DNA sensor involved in IFN-ß induction in response to WT bacteria.
In the same conditions, the ∆cdnP* mutant induced 1.6 to 2 times more IFN-ß in WT and cGAS -/-THP-1 cells compared with WT GBS strains ( Figure 4B ). The decreased IFN induction between WT and cGAS -/-THP-1 cells in response to the ∆cdnP* mutant (around 64%) is similar to the one observed with the WT bacteria controls ( Figure 4B ). Similar results were obtained by quantifying the production of the related IP-10 cytokine by ELISA ( Figure 4C ). These results indicate that the relative contribution of DNA sensing by cGAS is not affected by CdnP inactivation.
In contrast, we observed a similar low level of IFN-ß induction and IP-10 production by WT bacteria and the ∆cdnP* mutant when using STING -/-THP-1 cells ( Figures 4C and 4D ). The absence of a difference between WT and mutated bacteria in STING -/-THP-1 cells demonstrates that the increased IFN-ß induction is cGAS-independent and STING-dependent, suggesting a role for c-di-AMP in increased IFN-ß induction by ∆cdnP*. Indeed, cell transfection with c-di-AMP results in IFN-ß induction and IP-10 production in WT and cGAS -/-THP-1 cells (Figures 4B and 4C) but not in STING -/cells ( Figures 4D and 4E) . Similarly, incubation of digitoninpermeabilized THP-1 cells with a nucleotide fraction of GBS supernatants results in IFN-ß induction only with ∆cdnP* supernatants ( Figure S2C ). Addition of rCdnP to the purified ∆cdnP* supernatant or inactivation of STING abolished IFN-ß induction ( Figure S2C ). These results demonstrate that THP-1 cells induce more IFN-ß in response to infection with the ∆cdnP* mutant, and that this increase response is dependent on STING and on the increased amount of cdi-AMP present outside the mutated bacteria.
The same experiments were repeated in BMDMs to confirm the conserved role of c-di-AMP in IFN-ß induction. As observed with THP-1 cells, the ∆cdnP* mutant induced IFN-ß by a cGAS and STING-dependent pathway similar to the WT GBS but, in addition, activated a cGASindependent and STING-dependent pathway that accounts for the increased IFN-ß induction of the mutated strain ( Figure 4F and 4G). In both cell lines, no difference in phagocytosis, intracellular killing, and TNF- induction was observed for the three GBS strains in WT and mutated cell lines ( Figure S4 ). Overall, we conclude that the ∆cdnP* mutant induces a stronger IFN-ß response due to the cumulative effect of DNA recognition by cGAS, and c-di-AMP by a STING-dependent pathway. The DNA-cGAS pathway is similarly activated by the WT and the ∆cdnP* mutant, while the c-di-AMP-STING pathway is activated only by the ∆cdnP* mutant.
CdnP inactivation induces higher IFN-ß levels in vivo and reduces GBS virulence
Type I IFN is important for controlling GBS infection in mice (Mancuso et al., 2007) and our results showed that the GBS ∆cdnP* mutant induced higher IFN-ß levels in THP-1 and BMDMs. To test the effect of CdnP inactivation in vivo, we infected WT, cGAS -/and STING -/mice with GBS WT, WTbk, and the ∆cdnP* mutant. Consistent with our in vitro results, the ∆cdnP* mutant induced higher IFN-ß production in WT and cGAS -/mice, but not in STING -/mice, when compared to WT and WTbk bacteria ( Figure 5A) . The difference in IFN-ß induction observed with the ∆cdnP* mutant appears specific since TNF- induction is not affected by CdnP inactivation in the three mice backgrounds ( Figure 5B ). Interestingly, inactivation of cGAS or STING decreased the absolute level of IFN-ß induction for the three GBS strains, demonstrating the important role of the cGAS-STING pathway during in vivo infection ( Figure  5A ).
To confirm the link between IFN-ß level and the control of GBS infection, we quantified the number of bacteria in the blood and spleen. The WT and cGAS -/mice, but not the STING -/mice, infected by the ∆cdnP* mutant showed decreased bacteremia in both blood ( Figure 5C ) and spleen ( Figure 5D ) at 24 hours post-infection. Moreover cGAS or STING inactivation increased bacteremia, demonstrating their role to restrict bacterial infection by GBS ( Figure 5C and D). In conclusion, CdnP inactivation results in higher IFN-ß induction in mice and allows a more efficient control of the infection by a STING-dependent pathway. It is therefore likely that GBS expresses CdnP at its surface to degrade its own released c-di-AMP and to promote its virulence.
DISCUSSION
Type I IFNs are better known for their role in antiviral host defense, but they are likewise important in the host response to bacterial infection with favorable or detrimental outcomes to the host depending on the pathogen (McNab et al., 2015; Monroe et al., 2010) . Both viral and bacterial intracellular pathogens have been reported to induce type I IFNs by the cGAS/STING axis (Barber, 2014; Cai et al., 2014) . Given the conserved and ancient origin of this signaling pathway (Kranzusch et al., 2015) , it is likely that microbes have developed mechanisms to manipulate this innate immune sensing pathway. Consistently, viruses express specific proteins that increase infectiveness by interfering with cGAS or STING activation (Paludan, 2015; Wu et al., 2015; Ma and Damania, 2016) .
In this study, we demonstrated that type I IFN induction by the extracellular pathogen GBS is also dependent on the cGAS/STING axis. We identified cGAS as the main upstream sensor leading to IFN-ß production in response to WT GBS, in agreement with our previous study showing that GBS DNA is the main agonist of this response (Charrel-Dennis et al., 2008) .
However, we identified that WT GBS expresses a CdnP ectonucleotidase that degrades c-di-AMP outside the bacteria. Inactivation of CdnP leads to c-di-AMP accumulation outside GBS, higher levels of IFN- in vitro and in vivo, and reduced virulence, with lower bacterial burden in infected organs. The overproduction of IFN-ß is STING-dependent but cGAS-independent, showing that bacterial cdN can activate STING either directly or with the help of additional cdN receptors such as DDX41 (Danilchanka and Mekalanos, 2013; Parvatiyar et al., 2012) . By degrading its own c-di-AMP, GBS avoids the overactivation of STING, limits IFN-ß induction, and promotes its virulence.
To the best of our knowledge, a cdN catabolic activity at the bacterial surface has never been reported, or tested, in any species. Interestingly, CdnP is an enzyme belonging to the widespread ectonucleotidase family usually involved in nucleotide catabolism at the cell surface of prokaryotic and eukaryotic cells (Matange et al., 2015; Zimmermann et al., 2012) . This family of enzymes is structurally unrelated to the currently known bacterial cdN phosphodiesterases, which are all involved in the regulation of the intracellular concentration of cdN to control bacterial physiology (Corrigan and Grundling, 2013; Romling et al., 2013) . The current functional annotation in databases of CdnP suggests an activity on 2',3' cyclic nucleotides.
Although enzymes with this predicted activity are widespread, their biological functions are unknown (Matange et al., 2015; Wilson et al., 2012) probably because the predicted 2',3' cNMP substrates have never been detected in vivo and are unstable intermediates that do not require a specific enzyme for their degradation (Rao et al., 2010) . The CdnP activity on 3',5' cdN is therefore more likely to be a relevant physiological function instead of the activity on 2',3' cNMPs. CdnP is active on specific cdNs, being more potent on c-di-AMP, the only cdN synthesized by GBS, and unable to cleave the eukaryotic 2'3' cGAMP. Following this original CdnP enzymatic characterization, it is expected that other annotated 2',3' cNMP-degrading enzymes are in fact phosphodiesterases acting on specific cdNs.
Prior to this study, CdnP homologues in bacteria were identified but their biological functions have been elusive. The best-characterized homologue to date is the Vibrio cholera CdpB enzyme necessary for bacterial growth when extracellular DNA is the only phosphate source (McDonough et al., 2015) , but the nutritional function of extracellular cdN is unlikely.
The secretion or release of cdNs by bacteria is common and might be a way to regulate the intracellular pool of cdN in response to environmental stresses. However, cdNs have no known function outside bacteria. No effect on GBS growth was observed by inactivating CdnP, suggesting that the extracellular accumulation of c-di-AMP has no apparent physiological role in the tested conditions. In contrast, intracellular c-di-AMP synthesis is essential for bacterial growth in almost all conditions (Corrigan and Grundling, 2013; Whiteley et al., 2015) and we were unable to inactivate the only c-di-AMP synthase gene in GBS with our conventional methods (data not shown), suggesting that c-di-AMP synthesis is indeed essential for growth in standard condition.
The biological significance of having a dedicated c-di-AMP phosphodiesterase at the GBS surface becomes relevant when considering the host-pathogen relationship (Danilchanka and Mekalanos, 2013) . We found that IFN-ß induction by GBS-infected human and murine cells is dependent on cGAS, in agreement with GBS DNA as the main inducer of this TLR-independent response (Charrel-Dennis et al., 2008) . This result is also consistent with cGAS activation by DNA as predominant over bacterial cdN activation of STING, as observed recently with M.
tuberculosis (Collins et al., 2015; Wassermann et al., 2015; Watson et al., 2015) , L.
monocytogenes (Hansen et al., 2014) , and C. trachomatis . However, by inactivating CdnP in GBS, IFN-ß induction is increased and results from the additive effect on STING of the cGAS-synthesized 2'3' cGAMP in response to DNA and of the secreted bacterial c-di-AMP ( Figure 6 ). The increased amount of cdN outside bacteria has been previously linked to an increase in STING-dependent IFN-ß induction (Barker et al., 2013; Dey et al., 2015; Schwartz et al., 2012; Woodward et al., 2010) . Interestingly, we did not detect a CdnP homologue in L.
monocytogenes. This is not surprising since IFN-ß production has mainly negative effects on the host during infections by intracellular bacterial pathogens. It might even be possible that this pathogen class positively regulates the secretion of cdN to increase IFN-ß production. In contrast, IFN-ß is necessary for host protection against GBS and related pathogens. It is therefore advantageous for GBS to diminish STING activation by degrading c-di-AMP to promote invasion and organ colonization.
In conclusion, we extend the role of the cGAS-STING axis to the extracellular bacterial pathogen S. agalactiae and identified cGAS as the main sensor leading to IFN-ß production by infected macrophages. We also uncovered that wild-type GBS dampens IFN-ß production by degrading c-di-AMP due to the CdnP activity, thus avoiding the direct activation of STING. Our discovery shows the importance of c-di-AMP in the host immune response to GBS infection, and suggests that the development of CdnP inhibitors could be envisioned as a treatment strategy for infectious diseases.
EXPERIMENTAL PROCEDURES
Ethics Statement
All experiments involving animals were performed in accordance with guidelines set forth by the American Association for Laboratory Animal Science (AALAS) and were approved by the Institutional Animal Care and Use Committee (IACUC A-1332) at the University of Massachusetts Medical School (UMMS).
Bacterial strains and growth conditions
GBS strains used in this study are derivatives of NEM316, a ST-23 and serotype III clinical isolate (Glaser et al., 2002) . The ∆cylE non-hemolytic and the ∆nudP deletion mutant were described previously (Firon et al., 2014; Firon et al., 2013) . The ∆cdnP* mutant was constructed, as described in the supplemental experimental procedures, by mutating the His199-encoding codon to an Ala-encoding codon. The marker-less substitution and the isogenic WTbk control were confirmed by sequencing. Liquid cultures were maintained at 37°C in TH broth (TH, Difco-BD) or in a chemically defined medium (CDM).
Cells, cultures, and infections
WT, cGAS -/-, STING -/and IFI16 -/-THP-1 cells generated with CRISPR-Cas9 (Supplemental procedures and Figure S1 ) were grown in RPMI1640 supplemented with 4 mM glutamine and 10% FBS. Primary BMDMs from C57BL/6 mice were generated as described previously 
Quantitative RT-PCR and ELISA
Total RNA was extracted from infected cells using Trizol (Invitrogen) and one microgram of total RNAs was used for cDNA synthesis and quantitative PCR (Bio-Rad). Levels of human and mouse IFN-ß and TNF- were normalized against their respective GAPDH housekeeping genes.
Quantification by ELISA was performed on cell supernatants after the indicated time of infection as described for mouse IFN-ß (Roberts et al., 2007) and according to the manufacturer's instructions (R&D Research) for human CXCL10/IP-10 and mouse and human TNF-.
Quantification of GBS intracellular cdN by LC-MS/MS
Quantification of cdNs was performed by LC-MS/MS by BioLog Life Science GmbH using internal labeled standards. Extraction of cdNs on 5 ml of overnight GBS cultures was performed with Acetonitrile / Methanol / Water (2/2/1, v/v/v) buffer as recommended. Quantities of cdNs were normalized against the quantity of total protein extract.
Quantification of cdN and nucleotides by RR-HPLC
Rapid Resolution High Performance Liquid Chromatography (RR-HPLC) was used to determine kinetics of extracellular c-di-AMP degradation on whole GBS cells, extracellular c-di-AMP quantification, and for CdnP enzymatic characterization as described in supplemental experimental procedures. Reagents and standards were purchased from BioLog Life Sciences GmbH (c-di-AMP, c-di-GMP, cGAMP, 2'3' cGAMP, 2',3' and 3',5' cyclic NMPs) or from Sigma Aldrich (NMP, NDP, nucleotides, nucleosides).
Extracellular c-di-AMP degradation by GBS
GBS in early stationary phase were incubated with 0.1 mM c-di-AMP in 50 mM Tris and 5 mM MnCl2, at 37°C with agitation. Aliquots were taken at different times, centrifuged two times to eliminate bacteria, and the kinetics of c-di-AMP degradation and product formation was analyzed by RR-HPLC.
Quantification of extracellular c-di-AMP in GBS supernatants
Enrichment of c-di-AMP was done by affinity purification on 40 ml of GBS supernatants with the c-di-AMP binding protein CabP , as detailed in the supplemental experimental procedure. Relative quantification of extracellular c-di-AMP was performed by RR-HPLC with an external standard (40 ml of PBS containing 1.25 µM c-di-AMP) treated in the same condition to normalize samples.
Characterization of rCdnP enzymatic activities
Recombinant CdnP (residues 29-768) was produced in E. coli and analyzed by ultracentrifugation (An60Ti rotor, Beckman Coulter) as described in the supplemental experimental procedures. The rCdnP metallo-phosphatase activities were first assayed on 2',3' cyclic nucleotides by measuring the release of inorganic phosphate (Pi) with Malachite Green reagent (BIOMOL GREEN TM , Enzo Life Sciences). Inorganic phosphate (Pi) was quantified (absorbance at 620 nm) against a standard Pi curve. Kinetics with cdNs were done at 37°C in 50 mM Tris, pH 7.5, containing 5 mM MnCl2, 100-200 µM of substrates and 3 nM purified rCdnP enzyme. Substrate degradation and product formation were followed every 7 min by RR-HPLC.
In vivo infection and bacterial burden
6-week-old female C57BL/6 mice (Charles River) were injected intravenously with 1.5 x 10 7 CFUs of bacteria harvested during the exponential growth phase, washed in PBS, and resuspended in 100 μl. At 12 and 24 hrs after infection, mice were bled to evaluate serum IFN-ß levels. Bacterial counts in blood and spleen homogenates were determined by plating serial dilutions on blood agar plates.
Statistical Analysis
All in vitro data were analyzed using an unpaired, two-tailed Student's t test with a 95% confidence interval. In vivo data were analyzed using a non-parametric ANOVA (Kruskal-Wallis) (Prism; GraphPad Software, Inc.). Data are represented as means ± SD. Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F., Gambuzza, M., Macri, G., Ruggeri, A., et al. (2007) . Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 178, 3126-3133. Figure S1 (Related to Figure 1 ). STING expression in THP-1 CRISPR/Cas9 cells. Whole lysates from WT and STING KO THP-1 cells were subjected to western blotting using antibodies against STING and β-actin. Figure S2 (Related to Figures 2 and 4) . (C) Intracellular killing. GBS WT, WTbk, or ∆cdnP* mutant were used to infect THP-1 or BMDM and the corresponding cGAS and STING deficient cell lines at an MOI of 6 for 2 hrs (corresponding to time 0). The kinetics of bacterial killing was followed for 24 hrs by enumerating viable intracellular bacteria after cell lysis. Data are represented as mean ± SD of two independent experiments. (D) TNF induction. WT, cGAS -/and STING -/-THP-1 cells were infected with GBS WT, WTbk, or ∆cdnP* mutant (MOI-6) or transfected with c-di-AMP (100 nM) for 4 hr. Levels of TNF-α mRNA were determined by qPCR and normalized to GAPDH levels. Data are represented as mean ± SD of three experiments.
Manzanillo
Supplementary Experimental Procedures
Bacterial strains and growth conditions (Munier et al., 1992) and XL1 Blue (Stratagene) were grown in Luria-Bertani Broth (LB) medium. When specified, antibiotics were used at the following concentrations: for E. coli: erythromycin, 150 µg/ml; kanamycin, 30 µg/ml; chloramphenicol 30 µg/ml for GBS: erythromycin, 10 µg/ml.
Construction of the ∆cdnP* GBS mutant
The predicted CdnP catalytic histidine residue at position 199 was substituted with an alanine by replacing the corresponding codon on the GBS chromosome. Site-directed mutagenesis by a splicing by overlap-extension method, GBS transformation, and mutant isolation were done as described (Heckman and Pease, 2007; Firon et al., 2013; Firon et al., 2014) Briefly, two PCR products with overlapping ends containing the H 199 A substitution were generated with primers 418 + 419 (TCATGATTCACAAGTGGTTTAGCTGTTCAAGC and GTAATCTAAACCGTAATTAAACTCtgcATTACCTAGTGTTGATGCATCA) and 420 + 421 (TGATGCATCAACACTAGGTAATgcaGAGTTTAATTACGGTTTAGATTAC and ACTAGGATCCTTTCCATTGATACCATCAACTCC), mixed together in a second PCR reaction with the external primers 418 + 421, and cloned between the EcoRI-BamHI sites of the pG1 thermo-sensitive shuttle plasmid containing the erythromycin resistance gene. Transformation of GBS with the pG1ΩcdnP* vector was done by electroporation and selected on erythromycin at 30°C (permissive temperature for pG1 replication). Chromosomal integration of the pG1ΩcdnP* vector at the CdnP locus was obtained in the presence of erythromycin at 37°C (non-permissive temperature). Excision of the integrated vector can give the expected H 199 A substitution (the ∆cdnP* mutant) or can restore the wild type cdnP allele (corresponding to the isogenic WTbk control). The loss of pG1 was performed by serial dilutions at 30°C without antibiotic selection, followed by confirmation of erythromycin sensitivities at 37°C. After isolation at 37°C without antibiotic, analytic PCR was performed to differentiate the ∆cdnP* clones and the WTbk controls with ∆cdnP* specific primer pairs 422 + 423 (AGCGTATTCGCTTTAACTGTCTT and GTAATCTAAACCGTAATTAAACTCTGC) and 425 + 426 (TAGCACTACTTTCGGAGACTTGC and TGATGCATCAACACTAGGTAATGCA) and the WTbk specific primers pairs 422 + 424 (AGCGTATTCGCTTTAACTGTCTT and GTAATCTAAACCGTAATTAAACTCATG) and 425 + 427 (TAGCACTACTTTCGGAGACTTGC and TGATGCATCAACACTAGGTAATCAT). Sanger sequencing (GATC Biotech) was performed on 422 + 425 PCR products to confirm the mutated and the wild-type cdnP alleles in the corresponding strains.
Cell culture, and CRISPR/CAS9-Mediated Knockout Cell Line Generation
THP-1 cells (a human promonomyelocytic cell line) were grown in RPMI1640 supplemented with 4 mM glutamine and 10% fetal bovine serum (FBS). To generate targeted mutations, THP-1 cells were coelectroporated with a gRNA-and a mCherry-Cas9-expression plasmid as described (Schmid-Burgk et al., 2014) . The gRNA target sequences used were GAACTTTCCCGCCTTAGGCAGGG for cGAS (Wassermann et al., 2015) , TCCATCCATCCCGTGTCCCAGGG for STING, and CGGACACCTTACTCCCTTTG for IFI16. After FACS enrichment of mCherry-Cas9-positive cells, monoclones were grown for 2 weeks and were genotyped using deep sequencing. For each target gene, clones bearing all-allelic frameshift mutations were expanded for further study. Western blotting with cGAS, IFI16, STING and β-actin specific antibodies confirmed the absence of expression of the targeted protein. Primary BMDMs of WT, cGAS -/and STING -/mice were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL) supplemented with 4 mM glutamine and 10% FBS.
Cell infections
Cells were infected or stimulated as described (Charrel-Dennis et al., 2008) . Briefly, after an overnight culture without agitation at 37°C in THB made with endotoxin-free water, GBS cultures were diluted in THB and grown to mid-logarithmic phase (OD650 = 0.5). After two washes in PBS, GBS was used to stimulate cells at an MOI of 6 (except when stated). After 3h, ciprofloxacin 10 µg/ml was added to limit the growth of residual extracellular bacteria. Cells were harvested 6 hrs post-infection for RNA preparation (except when stated) followed by mRNA quantification by qRT-PCR. For protein quantification, cell culture supernatants were analyzed 18 hrs post-infection by ELISA. Transient transfections with GBS DNA and c-di-AMP (Biolog Life Science GmbH) were performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Phagocytosis and killing assays
For phagocytosis and killing assays, WT and mutated THP-1 and BMDMs were infected with GBS strains and viable intracellular bacteria were quantified by plating serial dilution on plates. For phagocytosis assays, cells were infected for 1, 2 and 4 hrs with the different GBS strains (MOI 6), extensively washed to remove extracellular bacteria and cells were resuspended in 0.5% saponin in sterile antibiotic-free medium containing 10% heat-inactivated FBS and incubated for 5 min at 37°C, then vortexed thoroughly to permeate cell membranes. The lysed cell mixture was serially diluted in sterile medium containing 0.5% saponin and cultured on 5% sheep blood agar plates overnight (Remel; Lenexa, KS). For the killing assay, cells were infected for 2 hrs, washed to remove extracellular bacteria and cells were lysed with 0.5% saponin, serially diluted and cultured on 5% sheep blood agar plates (at t 0 of infection). After 6, 16 and 24 hrs, cells were washed to remove extracellular bacteria, lysed, and plated as described before.
Quantitative RT-PCR
Total RNA was extracted from infected cells using Trizol (Invitrogen) according to the manufacturer's instructions. One microgram of total RNA was used for cDNA synthesis using iScript Select cDNA Synthesis Kit (Bio-Rad), and quantitative PCR was performed using iQ SYBR Green Supermix (Bio-Rad). The following primers were used: human IFNβ forward AGGACA GGATGAACTTTGAC and reverse TGATAGACATTAGCCAGGAG; human TNFα forward TGCTTGTTCCTCAGCCTCTT and reverse GGTTTGCTACAACATGGGCT; human GAPDH forward GAGTCAACGGATTTGGTCGT and reverse TTGATTTTGGAGGGATCTCG; mouse IFNβ forward TCCGAGCAGAGATCTTCAGGAA and reverse TGCAACCACCACTCATTCTGAG; mouse TNF-α forward CAGTTCTATGGCCCAGACCCT and reverse CGGACTCCGCAAAGTCTAAG; mouse GAPDH forward CGACTTCAACAGCAACTCCCACTCTTCC and reverse TGGGTGGTCCAGGGTTTCTTACTCCTT.
Quantification of GBS intracellular cdN by LC-MS/MS
Extraction of cdNs was performed on 5 ml of overnight bacterial cultures. After washing, bacterial pellets were resuspended in 300 µl of extraction buffer (Acetonitrile/Methanol/Water, 2/2/1, v/v/v), incubated at 4°C for 15 min, and heated at 95°C for 10 min. After centrifuging (20,800 g, 10 min, 4°C), supernatants were collected and the extraction was repeated twice with 200 µl of extraction buffer without the heating step. The three supernatants were pooled and dried (speed-vac). Quantification of cdNs was performed by LC-MS/MS by Biolog Life Science GmbH using internally labeled standards. Protein quantifications (BCA) were performed on 5 ml of overnight cultures in parallel of cdN extraction. Quantities of cdNs were normalized to the protein concentration of prepared supernatant samples.
Quantification of cdN and nucleotides by RR-HPLC
Rapid Resolution High Performance Liquid Chromatography (RR-HPLC) using a reverse-phase column (Agilent ZORBAX Eclipse XDB-C18, 2.1 x 50 mm, 1.8 µm) was used to determine kinetics of extracellular c-di-AMP degradation on whole GBS cells, extracellular c-di-AMP quantification, and for CdnP enzymatic characterization. Samples were analyzed by RR-HPLC with a flow rate of 0.25 ml/min and a linear gradient of 1-12% CH 3 CN (2-13% CH 3 CN or 1-90% CH 3 CN) in 20 mM triethylammonium acetate buffer, pH 7.5. Quantification was performed by comparing the peak areas of relevant cdN in the sample with those in standards of known concentrations.
Extracellular c-di-AMP degradation by GBS
Overnight cultures of GBS were diluted (1/100) and incubated at 37°C until they reached an OD 600 = 1, corresponding to the early stationary phase. After centrifugation (10 min, 4,000 rpm) and washing, pellets were resuspended in Tris 50 mM, pH 7.5, supplemented with 5 mM MnCl 2 (corresponding to the optimal assay condition for CdnP enzymatic activity). The cells were incubated at 37°C with agitation and the reaction started by adding 0.1 mM c-di-AMP (Biolog Life Science GmbH). Aliquots were taken at different time points, centrifuged two times to eliminate bacteria, and kinetics of c-di-AMP degradation and product formation were quantitated by RR-HPLC by integrating the corresponding nucleotide peak areas using known nucleotide standards as controls.
Quantification of c-di-AMP in GBS supernatants
To analyze the level of extracellular c-di-AMP in supernatants, GBS strains were cultured at 37 o C in 50 mL of CDM media until late exponential growth phase (A 600 = 0.6). Bacteria were eliminated by centrifugation (4,000 rpm, 10 min, 4°C) and the supernatant was subsequently pooled, concentrated on Vivaspin 20 kDa and purified on a Hi Load Superdex S200 column previously equilibrated with 50 mM Tris, 100 mM NaCl, pH 7.0, at a flow rate of 1 ml/min. SDS-PAGE electrophoresis and Coomassie Blue staining revealed a single protein (purity >98%) consistent with the predicted 80 kDa rCdnP-His molecular weight. Protein concentration was determined spectrophotometrically by UV absorption at 280nm using a ε 280 = 76670.
Analytical Ultracentrifugation
Sedimentation velocity experiments were carried out at 20°C in an XL-I analytical ultracentrifuge (Beckman Coulter). Samples (1 mg/ml) were spun down using an An60Ti rotor and 12-mm double sector epoxy centerpieces at 42,000 rpm and interference profiles were recorded every 5 min. Data were processed with the Sednterp software to estimate the partial specific volume of CdnP (0.732 ml/g), and the buffer viscosity (1.027 centipoises) and density (1.0044 g/ml). Sedimentation coefficient distributions, c(s), were determined using the software Sedfit 14.1. Sedimentation coefficients values are presented for standard conditions (in water at 20°C).
Enzymatic activity assays
To characterize the CdnP enzymatic parameters, its metallo-phosphatase activity was first assayed on 2',3' cyclic nucleotides by measuring the release of inorganic phosphate (P i ) using the Malachite Green reagent following the manufacturer's recommendations (BIOMOL GREEN TM , Enzo Life Sciences). The reaction was performed with 3 nM purified rCdnP at 37°C in 50 mM Tris adjusted to different pHs (between 5.5 and 8.5) and containing various concentrations of cofactors (Mn 2+ , Ca 2+ , Mg 2+ , Zn 2+ , Co 2+ ) and 2 mM of 2',3' cNMP. After stopping the reaction with 1 ml of BIOMOL GREEN TM reagent, samples were incubated at room temperature (20-30 min) and inorganic phosphate (P i ) was quantified by spectrophotometric absorbance measurements at 620 nm against a standard P i curves. Kinetics with cdN were done at 37°C in 50 mM Tris, pH 7.5, containing 5 mM MnCl 2 , 100-200 µM of substrates, and 3 nM purified rCdnP enzyme. Substrate degradation and product formation were followed every 7 min by RR-HPLC. Sequential degradation of cdN into nucleosides was done in the same conditions in the presence of an excess amount (50-250 nM) of the second ectonucleotidase rNudP purified as described. Quantification of Pi resulting from the sequential degradation of cdN by CdnP and NudP was done using the Malachite Green reagent.
